SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis
- DOI
- 10.1016/j.eclinm.2026.104117
- Published
- 2026-08
- Container
- eClinicalMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2026.104117,
title = {SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis},
author = {Po-Huang Chen and Wei-Cheng Chang and Hong-Jie Jhou and Hsin-Yu Chen and Mao-Hsuan Huang and Cho-Hao Lee},
year = {2026},
journal = {eClinicalMedicine},
doi = {10.1016/j.eclinm.2026.104117},
url = {https://doi.org/10.1016/j.eclinm.2026.104117}
}RIS
TY - JOUR TI - SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis AU - Po-Huang Chen AU - Wei-Cheng Chang AU - Hong-Jie Jhou AU - Hsin-Yu Chen AU - Mao-Hsuan Huang AU - Cho-Hao Lee PY - 2026 JO - eClinicalMedicine DO - 10.1016/j.eclinm.2026.104117 UR - https://doi.org/10.1016/j.eclinm.2026.104117 ER -
APA
Chen, P., Chang, W., Jhou, H., Chen, H., Huang, M., & Lee, C. (2026). SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104117
Source records
- crossref · retrieved 2026-09-27T15:08:57.943Z